SUN Pharmaceutical Industries Limited Isosorbide Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Isosorbide Export Records India — #9 Exporter, 44 Shipments, $482.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Isosorbide

India Pharmaceutical Trade Intelligence

$44.9M181 Suppliers102 CountriesHS 30049099

ExportsIndia → UNITED STATES85.6%India → UNITED KINGDOM3.1%

ImportsUNITED STATES → India$345.3K GERMANY → India$186.9K

#1 Buyer: TORRENT PHARMA

SUN Pharmaceutical Industries Limited — Isosorbide Exporter #9 | $482.6K Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Isosorbide Exporter Profile

Indian Pharmaceutical Exporter · #9 for Isosorbide · $482.6K export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #9 Indian exporter of Isosorbide with $482.6K in export value and 44 verified shipments. SUN Pharmaceutical Industries Limited holds a 1.1% market share in Isosorbide exports across 1 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Isosorbide Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Isosorbide export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Isosorbide?

Country	Value	Shipments	Share
UNITED STATES	$35.6M	712	85.2%
UNITED KINGDOM	$1.4M	81	3.4%
BRAZIL	$1.2M	40	2.8%
PHILIPPINES	$1.1M	52

Who Are the Top Buyers of Isosorbide from India?

Buyer	Country	Value	Orders
INGENUS PHARMACEUTICALS, LLC	UNITED STATES	$4.8M	96
TORRENT PHARMA INC	UNITED STATES	$4.5M	90
EVERSANA LIFE SCIENCES SERVICES LLC	UNITED STATES	$3.4M	105
INGENUS PHARMACEUTICALS LLC	UNITED STATES	$2.2M	44
WOODFIELD DISTRIBUTION LLC.	UNITED STATES	$1.2M	33
TORRENT PHARMA INC,	UNITED STATES	$1.1M	64
ZYDUS NIKKHO FARMACEUTICA LTDA	BRAZIL	$997.3K	35
INGENUS PHARMACEUTICALS,LLC	UNITED STATES	$850.0K	17
TORRENT PHARMA INC C/O,	UNITED STATES	$788.3K	26
WOODFIELD DISTRIBUTION LLC	UNITED STATES	$720.8K	16

India's Isosorbide is purchased by 537 buyers worldwide. The top buyer is INGENUS PHARMACEUTICALS, LLC (UNITED STATES), followed by TORRENT PHARMA INC and EVERSANA LIFE SCIENCES SERVICES LLC.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Isosorbide Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	RUBICON RESEARCH LIMITED	$993.3K	23	2	$43.2K
8	PAR FORMULATIONS PRIVATE LIMITED	$987.3K	44	1	$22.4K
9	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$482.6K	44	1	$11.0K
10	IND SWIFT LIMITED	$404.6K	12	1	$33.7K
11	INVENTIA HEALTHCARE LIMITED	$393.5K	20	1	$19.7K

SUN Pharmaceutical Industries Limited ranks #9 among 181 Indian Isosorbide exporters. Average shipment value of $11.0K compared to the market average of $164.5K. The closest competitors by value are RUBICON RESEARCH LIMITED and PAR FORMULATIONS PRIVATE LIMITED.

Which Indian Ports Ship Isosorbide Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	412	21.0%
SAHAR AIR	308	15.7%
NHAVA SHEVA SEA (INNSA1)	168	8.6%
Bombay Air	92	4.7%
JNPT/ NHAVA SHEVA SEA	86	4.4%
DELHI AIR	74	3.8%
HYDERABAD ICD	64	3.3%
DELHI AIR CARGO ACC (INDEL4)	52	2.7%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Isosorbide Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Isosorbide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 102+ countries, 537+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Isosorbide

Isosorbide

SUN Pharmaceutical Industries Limited — Isosorbide Exporter Profile

SUN Pharmaceutical Industries Limited — Isosorbide Export Profile: Buyers & Destinations

Where Does India Export Isosorbide?

Who Are the Top Buyers of Isosorbide from India?

What Is India's Total Isosorbide Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Isosorbide Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Isosorbide Exporters?

Regulatory Requirements: Exporting Isosorbide to Key Markets

United States — FDA

United Kingdom — MHRA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Isosorbide Exporters?

Which Indian Ports Ship Isosorbide Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Isosorbide Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Isosorbide Export Data from SUN Pharmaceutical Industries Limited

Isosorbide Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source